Rapport Therapeutics, Inc. (RAPP)
26.07
+1.63
(+6.67%)
USD |
NASDAQ |
Nov 09, 16:00
26.03
-0.04
(-0.15%)
After-Hours: 20:00
Rapport Therapeutics Net Income (Quarterly) : -40.24M for Sept. 30, 2026
Net Income (Quarterly) Chart
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2026 | -40.24M |
| June 30, 2026 | -56.62M |
| March 31, 2026 | -19.86M |
| December 31, 2025 | -33.76M |
| September 30, 2025 | -26.92M |
| June 30, 2025 | -26.73M |
| March 31, 2025 | -24.06M |
| December 31, 2024 | -19.98M |
| Date | Value |
|---|---|
| September 30, 2024 | -17.54M |
| June 30, 2024 | -18.12M |
| March 31, 2024 | -22.67M |
| December 31, 2023 | -13.52M |
| September 30, 2023 | -8.709M |
| June 30, 2023 | -6.411M |
| March 31, 2023 | -6.147M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (Quarterly) Benchmarks
| Johnson & Johnson | 210.00M |
| ANI Pharmaceuticals, Inc. | 32.72M |
| Corcept Therapeutics, Inc. | 124.49M |
| Veru, Inc. | -6.988M |
| Eli Lilly & Co. | 6.451B |
Net Income (Quarterly) Related Metrics
| Total Expenses (Quarterly) | 40.24M |
| EPS Diluted (Quarterly) | -0.8423 |
| Enterprise Value | 867.92M |
| Earnings Yield | -12.17% |
| Normalized Earnings Yield | -12.17 |